Tokyo, Oct. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063448) titled 'Effects of electrical stimulation of the ear on brain responses to reward a... Read More
Tokyo, Oct. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063446) titled 'Introduction of Exercise Therapy at the Dialysis Center An Initiative Focus... Read More
Tokyo, Oct. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063445) titled 'Effects of transcutaneous auricular vagus nerve stimulation (taVNS) on noci... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Sever... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... Read More
Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... Read More